IRIS Accounts Production v23.3.1.45 07716309 Board of Directors 1.1.23 31.12.23 31.12.23 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh077163092022-12-31077163092023-12-31077163092023-01-012023-12-31077163092021-12-31077163092022-01-012022-12-31077163092022-12-3107716309ns10:Originalns15:EnglandWales2023-01-012023-12-3107716309ns14:PoundSterlingns10:Original2023-01-012023-12-3107716309ns10:Originalns10:Director12023-01-012023-12-3107716309ns10:Original2023-01-012023-12-3107716309ns10:Original2023-12-3107716309ns10:Originalns10:PrivateLimitedCompanyLtd2023-01-012023-12-3107716309ns10:Originalns10:SmallEntities2023-01-012023-12-3107716309ns10:Originalns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3107716309ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3107716309ns10:SmallCompaniesRegimeForAccountsns10:Original2023-01-012023-12-3107716309ns10:Originalns10:FullAccounts2023-01-012023-12-3107716309ns10:Original12023-01-012023-12-3107716309ns10:Originalns10:Director22023-01-012023-12-3107716309ns10:CompanySecretary1ns10:Original2023-01-012023-12-3107716309ns10:Originalns10:RegisteredOffice2023-01-012023-12-3107716309ns10:Original2022-12-3107716309ns10:Originalns5:CurrentFinancialInstruments2023-12-3107716309ns10:Originalns5:CurrentFinancialInstruments2022-12-3107716309ns5:ShareCapitalns10:Original2023-12-3107716309ns5:ShareCapitalns10:Original2022-12-3107716309ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-12-3107716309ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-12-3107716309ns10:Originalns5:NetGoodwill2023-01-012023-12-3107716309ns5:IntangibleAssetsOtherThanGoodwillns10:Original2023-01-012023-12-3107716309ns10:Originalns5:PlantMachinery2023-01-012023-12-3107716309ns10:Original2022-01-012022-12-3107716309ns10:Originalns5:NetGoodwill2022-12-3107716309ns10:Originalns5:NetGoodwill2023-12-3107716309ns10:Originalns5:NetGoodwill2022-12-3107716309ns10:Originalns5:PlantMachinery2022-12-3107716309ns10:Originalns5:PlantMachinery2023-12-3107716309ns10:Originalns5:PlantMachinery2022-12-3107716309ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3107716309ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-3107716309ns10:Original1ns10:Director12022-12-3107716309ns10:Original1ns10:Director12021-12-3107716309ns10:Original1ns10:Director12023-01-012023-12-3107716309ns10:Original1ns10:Director12022-01-012022-12-3107716309ns10:Original1ns10:Director12023-12-3107716309ns10:Original1ns10:Director12022-12-31
REGISTERED NUMBER: 07716309 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

FOR

MOORE MEDICAL PRACTICE LIMITED

MOORE MEDICAL PRACTICE LIMITED (REGISTERED NUMBER: 07716309)






CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 31 December 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


MOORE MEDICAL PRACTICE LIMITED

COMPANY INFORMATION
for the year ended 31 December 2023







DIRECTORS: Dr S P G Moore
Dr A C Moore





SECRETARY: Dr A C Moore





REGISTERED OFFICE: 4 Comet House
Calleva Park
Aldermaston
Berkshire
RG7 8JA





REGISTERED NUMBER: 07716309 (England and Wales)





ACCOUNTANTS: Durrants - Calleva
Accountants and Tax Advisors
4 Comet House
Calleva Park
Aldermaston
Berkshire
RG7 8JA

MOORE MEDICAL PRACTICE LIMITED (REGISTERED NUMBER: 07716309)

BALANCE SHEET
31 December 2023

31/12/23 31/12/22
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 4,934 6,402
4,934 6,402

CURRENT ASSETS
Debtors 6 124,576 80,931
Cash at bank and in hand 1,548,336 1,060,213
1,672,912 1,141,144
CREDITORS
Amounts falling due within one year 7 251,596 200,678
NET CURRENT ASSETS 1,421,316 940,466
TOTAL ASSETS LESS CURRENT LIABILITIES 1,426,250 946,868

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 1,426,150 946,768
SHAREHOLDERS' FUNDS 1,426,250 946,868

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

MOORE MEDICAL PRACTICE LIMITED (REGISTERED NUMBER: 07716309)

BALANCE SHEET - continued
31 December 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29 January 2024 and were signed on its behalf by:





Dr S P G Moore - Director


MOORE MEDICAL PRACTICE LIMITED (REGISTERED NUMBER: 07716309)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 December 2023

1. STATUTORY INFORMATION

Moore Medical Practice Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents net invoiced sales of services, excluding value added tax.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2012, is being amortised evenly over its estimated useful life of ten years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

MOORE MEDICAL PRACTICE LIMITED (REGISTERED NUMBER: 07716309)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2023

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 6 (2022 - 6 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 January 2023
and 31 December 2023 1,270,000
AMORTISATION
At 1 January 2023
and 31 December 2023 1,270,000
NET BOOK VALUE
At 31 December 2023 -
At 31 December 2022 -

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 January 2023 59,248
Additions 175
At 31 December 2023 59,423
DEPRECIATION
At 1 January 2023 52,846
Charge for year 1,643
At 31 December 2023 54,489
NET BOOK VALUE
At 31 December 2023 4,934
At 31 December 2022 6,402

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31/12/23 31/12/22
£    £   
Trade debtors 28,623 44,860
Other debtors 95,953 36,071
124,576 80,931

MOORE MEDICAL PRACTICE LIMITED (REGISTERED NUMBER: 07716309)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2023

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31/12/23 31/12/22
£    £   
Trade creditors 69,757 80,874
Taxation and social security 181,839 119,804
251,596 200,678

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 December 2023 and 31 December 2022:

31/12/23 31/12/22
£    £   
Dr S P G Moore
Balance outstanding at start of year 26,969 -
Amounts advanced 44,772 26,969
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 71,741 26,969

9. ULTIMATE CONTROLLING PARTY

The controlling party is Drs A and S Moore.